Bruker´s Contribution to this Year´s Event


Bruker at the 32nd ECCMID

For the first time ever ECCMID will take place as a hybrid event, both onsite and online.  

Make yourself familiar with the latest product launches and diagnostic solutions Bruker offers to resolve healthcare challenges.


What´s new ?

Our Focus at ECCMID 2022

We will be discussing our latest developments at the show, highlighting:

  • The MALDI Biotyper® sirius IVD System, offering now even more value by dramatically increased analysis speed for routine microbial identification, thanks to the launch of MBT Compass HT IVD
  • The complementary and interrelated IR Biotyper®, enabling deeper analysis by providing fast and easy strain typing targeting hospital hygiene and epidemiology
  • The MBT Pathfinder® (coming soon), saving hands-on time by automated sample preparation for the MALDI Biotyper®
  • Our extensive Molecular Diagnostics portfolio, including
    o    The FluoroType® Approach - an integrated workflow from sample to result
    o    Assays for the detection of respiratory disease, Mycobacteria (incl. TB), STI, gastro-enteric diseases, infections of the immunocompromised host and other infectious diseases
    o    The powerful LiquidArray® technology to enable high level multiplexing for syndromic panels
  • The UMIC® product line for single drug MIC testing based on broth microdilution – with the coming soon UMIC® Cefiderocol

April 23 - Integrated Symposium

Integrated Symposium
Changing Microbiology: Focus to critical Infectious Diseases by State-of-the-Art Technologies
Saturday, April 23, 04:15-06:15 pm WEST

Chair: Dr. Belén Rodríguez Sánchez, Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital Gregorio Marañón, Madrid, Spain
Chair: Prof. Dr. med. Evgeny A. Idelevich, Universitätsmedizin Greifswald - Friedrich Loeffler-Institut für Medizinische Mikrobiologie, Germany


4:15-4:25 Welcome

4:25-4:50 MicrobeNet International: Building Pathogen Identification Capacity Worldwide
John R. McQuiston, Ph.D., Bacterial Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention (CDC), Atlanta/USA

4:50-5:15 Phenotypic Detection of Colistin Resistance – New Approaches
Sofia Somajo, Ph.D., Senior Lecturer in Biomedical Laboratory Science, Linnaeus University Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences, Sweden

5:15-5:40 Drug Resistant TB: Bridging the Gap between Treatment Regimens and Diagnostics
Margaretha de Vos, Ph.D., FIND, Geneva/Switzerland

5:40-6:05 Exploiting State-of-the-Art Technologies to Take Infectious Disease Diagnostics and Hygiene Control to the Next Level
Dr. Markus Kostrzewa, Senior Vice President R&D, Regulatory Affairs and Scientific Affairs, Microbiology & Diagnostics, Bruker Daltonics GmbH & Co. KG, Bremen/Germany

6:05-6:15 Panel Discussion and Q&A

Scientific Posters

Scientific Posters

Take a look on our poster list, covering a broad range of scientific and diagnostic topics that Bruker Microbiology & Diagnostics and its cooperation partners have recently worked on.